Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2

Status

Completed 76Terminated 15Unknown 13Recruiting 8Withdrawn 2Suspended 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 103Breast Neoplasms 80Neoplasms 74Neoplasm Metastasis 64Melanoma 64Leukemia, Myeloid, Acute 58Lymphoma, Non-Hodgkin 53Ovarian Neoplasms 52Multiple Myeloma 50Glioblastoma 49Colorectal Neoplasms 49Prostatic Neoplasms 48Pancreatic Neoplasms 47Lung Neoplasms 45Recurrence 42Carcinoma, Renal Cell 41Leukemia, Lymphocytic, Chronic, B-Cell 38Squamous Cell Carcinoma of Head and Neck 36Triple Negative Breast Neoplasms 34Myelodysplastic Syndromes 31Glioma 29Stomach Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, B-Cell 27Brain Neoplasms 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Follicular 25Lymphoma 25Endometrial Neoplasms 24Carcinoma, Hepatocellular 23

Interventions

temsirolimus 1Vorinostat 1Sirolimus 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × Advanced Cancer × Clear all
NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
249 enrolled

Advanced Cancer

NCT05735496 2025-08-01

Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Active not recruiting
219 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡